The Vanguard Group, Inc. recently announced the acquisition of new stake in Catalent Inc. (NYSE:CTLT). The institutional investor has increased its shareholding in the Healthcare company by 1.89% to 18.86 million shares with purchase of 0.35 million shares. This fresh investment now brings its stake to 10.52% valued currently at $1.29 billion. In addition, Capital Research & Management Co raised its holdings by 2.41 million to 13.82 million shares. And Veritas Asset Management LLP has lifted its position by 60.54% or 4.21 million shares – to 11.17 million shares.
With over 3.11 million Catalent Inc. (CTLT) shares trading Monday and a closing price of $65.67 on the day, the dollar volume was approximately $204.41 million. The shares have shown a negative half year performance of -31.57% and its price on 03/13/23 lost nearly -3.31%. Currently, there are 181.00M common shares owned by the public and among those 179.31M shares have been available to trade.
From Robots to Self-Driving Cars: 5 AI Stocks to Consider for Your Portfolio
The artificial intelligence (AI) revolution is already here and it's about to change everything we know about everything. With the global market for AI projected to grow from $137 billion in 2022 to over $1.81 trillion by 2030, there's never been a better time to invest in this burgeoning industry. That's why we've compiled a list of the Top 5 AI Stocks to Buy for 2023. These companies are at the forefront of the AI revolution, and have the potential to deliver huge returns to investors like you.
Get our free report, "Top 5 AI Stocks to Buy for 2023".
An analysis of what Wall Street brokers have to say about the expected price targets for this stock gives us this picture: 15 analysts who have offered their price forecasts for CTLT have a consensus price objective of $81.83. The analysts have set the share’s price value over the next 12 months at a high of $90.00 and a low of $57.00. The average price target is 16.79% above its recent price level and a downside to the estimated low will see the stock lose -15.21% over that period. But an upside of 27.03% will see the stock hit the forecast high price target while median target price for the stock is $84.00.
Insiders at the company have transacted a total of 91 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 47 of these insider trades were purchases, accounting for 315,487 shares. Insider sales of the common stock occurred on 44 occasions, with total insider shares sold totaling 103,816 shares.
The top 3 mutual fund holders in Catalent Inc. are Vanguard Total Stock Market Index, T Rowe Price Mid Cap Growth Fund, and American Funds New Perspective Fu. Vanguard Total Stock Market Index owns 5.25 million shares of the company’s stock, all valued at over $358.05 million. The company bought an additional 40809.0 shares recently to bring their total holdings to about 2.93% of the shares outstanding. T Rowe Price Mid Cap Growth Fund sold -0.15 million shares to see its total holdings shrink to 5.15 million shares valued at over $351.28 million and representing 2.87% of the shares outstanding. American Funds New Perspective Fu bought 1.1 million shares to bring its total holdings to over 4.68 million shares at a value of $319.38 million. American Funds New Perspective Fu now owns shares totaling to 2.61% of the shares outstanding.
Shares of Catalent Inc. (NYSE: CTLT) opened at $67.14, down -$0.78 from a prior closing price of $67.92. However, the script later moved the day high at 67.39, down -3.31%. The company’s stock has a 5-day price change of -7.95% and 44.20% over the past three months. CTLT shares are trading 45.90% year to date (YTD), with the 12-month market performance down to -33.21% lower. It has a 12-month low price of $40.69 and touched a high of $115.33 over the same period. CTLT has an average intraday trading volume of 2.50 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -5.67%, 10.78%, and -14.54% respectively.
Institutional ownership of Catalent Inc. (NYSE: CTLT) 181.00M shares outstanding. Mutual fund holders own 39.45%, while other institutional holders and individual stakeholders account for 63.18% and 17.77% respectively.
It has a market capitalization of $12.18B and a beta (3y monthly) value of 1.18. The stock’s trailing 12-month PE ratio is 29.06, while the earnings-per-share (ttm) stands at $2.26. The company has a PEG of 4.02 and a Quick Ratio of 1.40 with the debt-to-equity ratio at 0.99. Price movements for the stock have been influenced by the stock’s volatility, which stands at 4.60% over the week and 3.67% over the month.
Analysts forecast that Catalent Inc. (CTLT) will achieve an EPS of $0.72 for the current quarter, $1.43 for the next quarter and $3.57 for 2024. The lowest estimate earnings-per-share for the quarter is $0.53 while analysts give the company a high EPS estimate of $0.97. Comparatively, EPS for the current quarter was $1.04 a year ago. Earnings per share for the fiscal year are expected to decrease by -9.20%, and 11.22% over the next financial year. EPS should shrink at an annualized rate of 7.24% over the next five years, compared to 26.70% over the past 5-year period.
If you are looking to buy this stock, then you may note that the average analyst recommendation by 15 brokerage firm advisors rate Catalent Inc. (CTLT) as a “Moderate Buy” at a consensus score of 2.10. Specifically, 8 Wall Street analysts polled rate the stock as a buy, while 3 of the 15 advise that investors “hold,” and 1 rated it as a “Sell.”
BofA Securities was of a view on November 02, 2022 that the stock is Neutral, while Barclays gave the stock Overweight rating on December 16, 2021, issuing a price target of $160. KeyBanc Capital Markets on their part issued Overweight rating on December 10, 2020.
Leave a Reply